In adults with ATTR cardiac amyloidosis, patisiran reduced decline in functional capacity at 12 mo

Ahmad Masri; Harriette G.C. Van Spall

doi:10.7326/J24-0004

In adults with ATTR cardiac amyloidosis, patisiran reduced decline in functional capacity at 12 mo

Ahmad Masri, Harriette G.C. Van Spall

Knight Cardiovascular Institute

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	JC30
Journal	Annals of internal medicine
Volume	177
Issue number	3
DOIs	https://doi.org/10.7326/J24-0004
State	Published - Mar 1 2024

ASJC Scopus subject areas

Internal Medicine

Access to Document

10.7326/J24-0004

Cite this

@article{e4b67d7cbf3e4cbcb84e7826e73a3a3a,

title = "In adults with ATTR cardiac amyloidosis, patisiran reduced decline in functional capacity at 12 mo",

author = "Ahmad Masri and {Van Spall}, {Harriette G.C.}",

year = "2024",

month = mar,

day = "1",

doi = "10.7326/J24-0004",

language = "English (US)",

volume = "177",

pages = "JC30",

journal = "Annals of internal medicine",

issn = "0003-4819",

publisher = "American College of Physicians",

number = "3",

}

TY - JOUR

T1 - In adults with ATTR cardiac amyloidosis, patisiran reduced decline in functional capacity at 12 mo

AU - Masri, Ahmad

AU - Van Spall, Harriette G.C.

PY - 2024/3/1

Y1 - 2024/3/1

UR - http://www.scopus.com/inward/record.url?scp=85188480194&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85188480194&partnerID=8YFLogxK

U2 - 10.7326/J24-0004

DO - 10.7326/J24-0004

M3 - Comment/debate

C2 - 38437698

AN - SCOPUS:85188480194

SN - 0003-4819

VL - 177

SP - JC30

JO - Annals of internal medicine

JF - Annals of internal medicine

IS - 3

ER -

In adults with ATTR cardiac amyloidosis, patisiran reduced decline in functional capacity at 12 mo

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this